Red Light Therapy Side Effects on Darker Skin Tones
Red light therapy is generally well tolerated, but darker skin tones need lower dose thresholds. Learn the side effects and how to use LED safely
Red light therapy side effects are the adverse reactions that can occur during photobiomodulation treatment, including temporary redness, hyperpigmentation, and in rare cases blistering, with clinical evidence showing that darker skin tones (Fitzpatrick types IV to VI) have lower safe dose thresholds and require adjusted treatment parameters to minimize risk.
Most articles about red light therapy focus on the benefits. This one is about what can go wrong, who is most at risk, and how to use these devices safely. The overall safety profile of red light therapy is strong. Multiple systematic reviews confirm that adverse events are uncommon and typically mild 12. But "generally safe" is not the same as "safe for everyone at every dose." Two randomized controlled trials found that darker skin tones are more photosensitive to red LED light, with dose-limiting adverse events occurring at fluences that lighter skin tolerated without issue 3. That is a critical finding that most consumer marketing ignores entirely.
Key Takeaways:
- Red light therapy is well-tolerated by most people, with the most common side effect being mild, temporary redness 1
- Darker skin tones (Fitzpatrick IV-VI) showed dose-limiting adverse events at 480 J/cm2, including blistering and prolonged erythema, while lighter skin tolerated the same dose 3
- Safe fluence thresholds differ by skin tone: up to 320 J/cm2 for skin of color versus 480 J/cm2 for lighter skin types 3
- Photosensitizing medications (tetracyclines, certain diuretics, NSAIDs) may increase risk of adverse reactions 4
- Post-inflammatory hyperpigmentation is a documented risk, particularly for melanin-rich skin 5
What are the most common side effects of red light therapy?
The most frequently reported side effect is transient erythema, which is mild redness at the treatment site that resolves within 24 to 48 hours. A systematic review of photobiomodulation safety across multiple clinical applications found no pattern of serious adverse events when devices were used within established parameters 1. The treatment is non-thermal at standard consumer doses, meaning it does not heat your skin enough to cause burns under normal use conditions.
That said, "normal use conditions" is doing a lot of work in that sentence. Exceeding recommended treatment times, using damaged devices with inconsistent output, or combining light therapy with photosensitizing agents can change the risk profile significantly. Documented side effects from clinical trials include temporary redness lasting 24 to 48 hours, mild warmth or tingling during treatment, transient hyperpigmentation in susceptible individuals, eye irritation when protection is not used, and in rare cases at high fluences, blistering 36.
Most of these are dose-dependent. At the power densities delivered by consumer LED masks (5 to 50 mW/cm2), serious side effects are rare in published literature. The problems arise at higher doses or in individuals with specific risk factors.
Why does skin color affect red light therapy safety?
The research on this question is important and worth understanding. A pair of randomized controlled trials by Jagdeo et al. specifically tested the safety of LED red light across different skin tones, and the results were significant 3. Darker skin (classified as "skin of color" in the study) showed dose-limiting adverse events at 480 J/cm2, including blistering and prolonged erythema. The same fluence was tolerated by lighter-skinned participants. The study established that the safe threshold for skin of color was 320 J/cm2, a full 33% lower than for non-Hispanic Caucasian skin.
The mechanism involves melanin. Melanin absorbs light across a broad spectrum, including the red wavelengths used in photobiomodulation 7. More melanin means more light absorption in the epidermis, which translates to more heat generation in the superficial skin layers. This increased absorption is also why red light penetration depth is reduced in darker skin: a study measuring transmittance found that darker skin reflects and absorbs more red light, leaving less to reach the target cells in the dermis 7.
What this means for your treatment
If you have Fitzpatrick skin type IV, V, or VI, the standard device settings and treatment times marketed for general use may deliver a higher effective dose to your epidermis than intended. This does not mean red light therapy is unsafe for darker skin. It means the dose needs adjusting. A 2024 review in the Journal of the American Academy of Dermatology emphasized that photobiomodulation wavelengths can induce varied biological effects across diverse skin types and that dermatologists should counsel skin of color patients on appropriate treatment parameters 5.
What is the hyperpigmentation risk?
Post-inflammatory hyperpigmentation (PIH) is the most concerning potential side effect for people with melanin-rich skin. When the epidermis is irritated or inflamed, even mildly, melanocytes can respond by overproducing melanin. The result is dark patches that can take months to fade. This risk is documented for various light-based therapies in skin of color populations 8.
For red light therapy specifically, hyperpigmentation has been reported as a mild adverse event in clinical trials 3. The risk is dose-dependent: staying within appropriate fluence limits significantly reduces the likelihood. An integrative review of photobiomodulation for melasma noted that while certain wavelengths can actually reduce hyperpigmentation at appropriate doses, excessive doses may stimulate melanocyte activity in susceptible individuals 9. The relationship between light dose and pigmentation response is not linear. It follows the same biphasic pattern seen in other photobiomodulation effects. A little helps. Too much hurts.
| Risk factor | How it increases side effect risk | What to do |
|---|---|---|
| Fitzpatrick type IV-VI | Higher melanin absorption increases epidermal heating | Start at 50% recommended time, increase gradually |
| Photosensitizing medication | Amplifies skin's light reactivity | Consult your dermatologist before starting |
| Recent chemical peel or retinoid use | Compromised barrier increases sensitivity | Wait 48-72 hours after exfoliation |
| Broken or inflamed skin | Increased absorption at wound sites | Avoid treating active breakouts or wounds |
| Prolonged session times | Exceeds safe fluence thresholds | Follow device time limits strictly |
Which medications interact with red light therapy?
Photosensitizing medications increase your skin's reactivity to light, and this applies to red light wavelengths as well as UV. The drug classes most commonly associated with photosensitivity reactions are tetracycline antibiotics (including doxycycline and minocycline), certain diuretics (particularly hydrochlorothiazide), nonsteroidal anti-inflammatory drugs (NSAIDs like naproxen and piroxicam), fluoroquinolone antibiotics, and some retinoids 4.
A review of laser therapy in patients taking photosensitizing medication found that, among the limited published case studies, no complications were reported 10. But the authors noted that the evidence base is thin, and caution is warranted. If you are taking any medication that carries a photosensitivity warning, talk to your prescribing doctor or dermatologist before adding red light therapy to your routine. The Skin Bliss Ingredient Compatibility Checker can flag photosensitizing ingredients in your topical products, but systemic medications require professional guidance.
How can you minimize side effects with darker skin?
Start with conservative parameters and scale up. This is what the clinical data supports 3. Here are practical steps based on the research:
Begin with 50% of the manufacturer's recommended treatment time for your first two weeks. Monitor your skin for any redness lasting more than a few hours, unusual warmth, or pigmentation changes. If tolerated, increase by 25% increments every two weeks until reaching full treatment time. Use 3 sessions per week initially rather than daily. Document your skin before starting treatment and at weekly intervals so you can spot subtle changes early.
Keep a log of how your skin responds after each session. If you notice persistent redness beyond 24 hours, scale back. If you see any darkening or pigmentation change in treated areas, stop and consult a dermatologist. These responses are uncommon at consumer device power levels, but catching them early prevents them from becoming a bigger problem.
What about eye safety with LED masks?
Eye protection deserves its own section because the risks are real and preventable. Red and near-infrared light can reach the retina, and while therapeutic doses are not the same as laser exposure, cumulative effects on retinal tissue are not fully understood for long-term consumer use 11. A 2026 safety evaluation of red light therapy devices found that some laser-based devices deliver irradiance levels reaching safety limits within shorter exposure times than their recommended treatment duration 12.
LED-based devices are lower risk than laser devices for eye exposure, but the principle holds: use the eye shields or goggles that come with your device. If your device does not include eye protection, purchase IEC-certified LED safety goggles separately. Never assume that closing your eyes is sufficient protection, as red and near-infrared wavelengths penetrate the eyelids.
Frequently asked questions
Can red light therapy cause cancer or promote tumor growth?
A systematic review specifically examining the oncologic safety of low-level light therapy for aesthetic skin rejuvenation found no evidence linking photobiomodulation to increased cancer risk 1. Within established treatment parameters, red and near-infrared light primarily enhances proliferation of healthy cells without promoting malignant growth. This is one of the most thoroughly investigated safety questions in the photobiomodulation literature.
Is red light therapy safe during pregnancy?
There are no clinical trials evaluating red light therapy safety during pregnancy. In the absence of evidence, most dermatologists recommend avoiding it as a precaution, particularly over the abdominal area. Facial use is likely lower risk, but the conservative approach is to wait. Discuss with your OB-GYN if you want to continue treatment during pregnancy.
How do I know if my skin is reacting badly to red light therapy?
Normal: mild pinkness that fades within 1 to 2 hours. Concerning: redness lasting beyond 24 hours, tenderness, any blistering, or new dark spots in the treatment area. If you experience any of the concerning signs, discontinue use and consult a dermatologist. For people with darker skin tones, check for subtle pigmentation changes by comparing treated areas to adjacent untreated skin in consistent lighting 3.
Should I avoid red light therapy if I have melasma?
The research is mixed. Some studies suggest that specific photobiomodulation wavelengths and doses can actually improve melasma by modulating melanocyte activity 9. But the wrong dose can worsen it. If you have melasma, this is a situation where professional guidance is essential rather than self-treating with a consumer device. A dermatologist can determine whether your melasma type might benefit from or be aggravated by red light therapy.
What Fitzpatrick skin type am I?
Fitzpatrick skin typing classifies skin into six categories based on your tendency to burn versus tan after sun exposure. Types I-II are very fair to fair skin that burns easily. Types III-IV are medium to olive skin that tans moderately. Types V-VI are brown to very dark brown skin that rarely burns 13. If you are unsure, the Skin Bliss Face Scanner can help assess your skin characteristics and personalize recommendations accordingly.
Sources
- Barolet D et al. (2023). "Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation." *Aesthetic Surgery Journal*.
- Hamblin MR. (2017). "Mechanisms and applications of the anti-inflammatory effects of photobiomodulation." *AIMS Biophysics*.
- Jagdeo J et al. (2019). "Safety of light emitting diode-red light on human skin: Two randomized controlled trials." *Journal of Biophotonics*.
- Monteiro E et al. (2022). "Photosensitizing drug reactions." *Dermatologic Clinics*.
- Alexis AF et al. (2024). "Photobiomodulation CME part II: Clinical applications in dermatology." *Journal of the American Academy of Dermatology*.
- Wunsch A, Matuschka K. (2014). "A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase." *Photomedicine and Laser Surgery*.
- Souza-Barros L et al. (2018). "Skin color and tissue thickness effects on transmittance, reflectance, and skin temperature when using 635 and 808 nm lasers in low intensity therapeutics." *Lasers in Medical Science*.
- Alexis AF et al. (2013). "Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI." *British Journal of Dermatology*.
- Moreira Moreno LH et al. (2023). "Photobiomodulation for melasma treatment: Integrative review and state of the art." *Photodermatology, Photoimmunology & Photomedicine*.
- Haedersdal M et al. (2014). "Laser therapy and photosensitive medication: a review of the evidence." *Lasers in Surgery and Medicine*.
- Brouwer A et al. (2017). "Light therapy: is it safe for the eyes?" *Acta Psychiatrica Scandinavica*.
- Wu Y et al. (2026). "Safety Evaluation of 4 Red Light Therapy Devices for Myopia." *Ophthalmology*.
- Sachdeva S. (2009). "Fitzpatrick skin typing: Applications in dermatology." *Indian Journal of Dermatology, Venereology and Leprology*.
